These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6291565)

  • 1. The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
    McNally NJ
    Br J Cancer; 1982 Oct; 46(4):670-4. PubMed ID: 6291565
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ; Hinchliffe M; de Ronde J
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
    Martin WM; McNally NJ; De Ronde J
    Br J Cancer; 1981 Jun; 43(6):756-66. PubMed ID: 7248157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of cyclophosphamide and misonidazole in the KHT sarcoma.
    Siemann DW; Sutherland RM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):647-50. PubMed ID: 7107391
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemosensitization by lipophilic nitroimidazoles.
    Twentyman PR; Workman P
    Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitizers and protectors in clinical oncology.
    Phillips TL
    Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM; Hirst DG
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental radiotherapy with WR-2721 and misonidazole.
    Rojas A; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):527-30. PubMed ID: 6286547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
    Twentyman PR
    Br J Cancer; 1983 Jan; 47(1):57-63. PubMed ID: 6295428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR; Evans JW; Brown JM
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the chemosensitization of melphalan by misonidazole.
    Randhawa VS; Stewart FA; Denekamp J; Stratford MR
    Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP; Hirst DG; Brown JM
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P; Workman P
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW; Maddison K; Wolf K
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF
    Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of mouse lung tumors to combinations of CCNU and misonidazole.
    Siemann DW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):627-30. PubMed ID: 7107386
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of combining the radiosensitizer misonidazole with cyclophosphamide in treating the murine Lewis lung tumor.
    Pedersen JE; Barron G; Meeker BE
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):651-3. PubMed ID: 7107392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.